newsfilter
← Latest News
PR Newswire·

Provention Bio Announces $60 Million Private Placement

RED BANK, N.J., July 7, 2022 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced it has entered into a securities purchase agre